Literature DB >> 23030325

Managing tuberculosis in patients with diabetes mellitus: why we care and what we know.

Christie Y Jeon1, Megan B Murray, Meghan A Baker.   

Abstract

As the global prevalence of diabetes mellitus (DM) increases, especially in low-to-middle income countries where tuberculosis (TB) remains endemic, we will encounter a growing number of TB patients with DM. This is a major concern for TB control programs, clinicians and patients alike because DM patients are at an increased risk of TB and are more likely to face poor TB treatment outcomes, including treatment failure, relapse and even death. Priority should be placed on early detection of both diseases through active screening, monitoring of adherence to medications for both diseases, and integration of TB and DM management strategies that would facilitate the provision of more comprehensive services that TB patients with DM require.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23030325     DOI: 10.1586/eri.12.75

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  12 in total

Review 1.  Diabetes and Tuberculosis.

Authors:  Blanca I Restrepo
Journal:  Microbiol Spectr       Date:  2016-12

2.  Maxillary sinusitis with pulmonary tuberculosis.

Authors:  Rashmi Upadhyay; Ved Prakash; Abhishek Bahadur Singh; S Saheer
Journal:  BMJ Case Rep       Date:  2014-08-01

Review 3.  New screening technologies for type 2 diabetes mellitus appropriate for use in tuberculosis patients.

Authors:  T Adepoyibi; B Weigl; H Greb; T Neogi; H McGuire
Journal:  Public Health Action       Date:  2013-11-04

Review 4.  Impact of diabetes on the natural history of tuberculosis.

Authors:  Blanca I Restrepo; Larry S Schlesinger
Journal:  Diabetes Res Clin Pract       Date:  2014-07-14       Impact factor: 5.602

5.  Increased severity of tuberculosis in Guinea pigs with type 2 diabetes: a model of diabetes-tuberculosis comorbidity.

Authors:  Brendan K Podell; David F Ackart; Andres Obregon-Henao; Sarah P Eck; Marcela Henao-Tamayo; Michael Richardson; Ian M Orme; Diane J Ordway; Randall J Basaraba
Journal:  Am J Pathol       Date:  2014-01-31       Impact factor: 4.307

6.  Educational counselling of patients with combined TB and diabetes mellitus: a randomised trial.

Authors:  R C Koesoemadinata; S M McAllister; N N M Soetedjo; P Santoso; R Ruslami; H Damayanti; N Rahmadika; B Alisjahbana; R van Crevel; P C Hill
Journal:  Public Health Action       Date:  2021-12-21

7.  Predicting treatment failure, death and drug resistance using a computed risk score among newly diagnosed TB patients in Tamaulipas, Mexico.

Authors:  B E Abdelbary; M Garcia-Viveros; H Ramirez-Oropesa; M H Rahbar; B I Restrepo
Journal:  Epidemiol Infect       Date:  2017-09-14       Impact factor: 4.434

8.  Changes in glycosylated haemoglobin and treatment outcomes in patients with tuberculosis in Iran: a cohort study.

Authors:  Payam Tabarsi; Parvaneh Baghaei; Majid Marjani; William M Vollmer; Mohammad-Reza Masjedi; Anthony D Harries
Journal:  J Diabetes Metab Disord       Date:  2014-12-16

9.  Diabetes Mellitus and Increased Tuberculosis Susceptibility: The Role of Short-Chain Fatty Acids.

Authors:  Ekta Lachmandas; Corina N A M van den Heuvel; Michelle S M A Damen; Maartje C P Cleophas; Mihai G Netea; Reinout van Crevel
Journal:  J Diabetes Res       Date:  2015-12-29       Impact factor: 4.011

Review 10.  Clinical and pharmacological hallmarks of rifapentine's use in diabetes patients with active and latent tuberculosis: do we know enough?

Authors:  Chunlan Zheng; Xiufen Hu; Li Zhao; Minhui Hu; Feng Gao
Journal:  Drug Des Devel Ther       Date:  2017-10-11       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.